SillaJen Inc
KOSDAQ:215600
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SillaJen Inc
KOSDAQ:215600
|
KR |
Intrinsic Value
The intrinsic value of SillaJen Inc (215600) under the Base Case is 1 033.67 KRW per share. Compared with the current market price of 2 160 KRW, the stock appears Overvalued by 52% .
The intrinsic value is calculated using the DCF method. Operating margin recovers from -277% last year to -100% by 2033. Revenue grows about 16% in 2026, then slows: about 0% a year on average over the next five years, less than a third of its five-year pace of 41%. The forecast years subtract value, so the estimate rests entirely on the years after 2033.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What SillaJen Does
SillaJen Inc is a South Korean biotechnology company that focuses on developing cancer treatments based on oncolytic viruses, which are engineered viruses designed to attack tumor cells while sparing healthy tissue. Its work is centered on researching and testing experimental drug candidates rather than selling a broad range of commercial medicines.
- Headquarters
- Korea KR
- IPO date
- Dec 6, 2016
Revenue & Expenses Breakdown
SillaJen Inc
Earnings Waterfall
SillaJen Inc
The intrinsic value for SillaJen Inc (215600) under the Base Case is 1 033.67 KRW.
Compared with the current market price of 2 160 KRW, the stock appears Overvalued by 52% .